Clinical Trial Update: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating MM-121 in combination with paclitaxel in patients with advanced gynecologic cancers and HER2-non-overexpressing breast cancer; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• MM-121 (seribantumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,, Primary Peritoneal Cancer or Endometrial Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-09-08